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ABSTRACT
Tetracycline repressor (TetR)-controlled expres-
sion systems have recently been developed for
mycobacteria and proven useful for the construc-
tion of conditional knockdown mutants and their
analysis in vitro and during infections. However,
even though these systems allowed tight regula-
tion of some mycobacterial genes, they only
showed limited or no phenotypic regulation for
others. By adapting their codon usage to that
of the Mycobacterium tuberculosis genome, we
created tetR genes that mediate up to ~50-fold
better repression of reporter gene activities in
Mycobacterium smegmatis and Mycobacterium
bovis BCG. In addition to these repressors, for
which anhydrotetracycline (atc) functions as an
inducer of gene expression, we used codon-usage
adaption and structure-based design to develop
improved reverse TetRs, for which atc functions as
a corepressor. The previously described reverse
repressor TetR only functioned when expressed
from a strong promoter on a multicopy plasmid.
The new reverse TetRs silence target genes more
efficiently and allowed complete phenotypic silenc-
ing of M. smegmatis secA1 with chromosomally
integrated tetR genes.
INTRODUCTION
Bacterial genomes encode hundreds of genes whose
functions yet remains to be discovered. For example, the
genome of the important human pathogen Mycobacterium
tuberculosis contains more than 1000 genes whose func-
tions are unknown (1). Approximately 20% of these are
likely required by M. tuberculosis to form colonies on agar
plates (2). In this organism, genes of unknown functions
are, thus, not only abundant but also frequently essential
for growth. Reverse genetics allow to systematically
associate genes of unknown function with speciﬁc biolog-
ical processes and can provide an initial functional classi-
ﬁcation. Application of this approach to genes essential
for in vitro growth requires the construction of condi-
tional mutants, because bacteria, in which a growth essen-
tial gene has been constitutively inactivated, cannot be
obtained in amounts suﬃcient for further analyses. A
straightforward method for obtaining conditional mutants
is to replace the native promoter of a target gene with a
tightly regulated promoter whose activity can be con-
trolled experimentally (3–7).
The promoters that initiate transcription of tetracycline
(tc) eﬄux pump encoding genes in Gram-negative bacteria
are among the most tightly regulated bacterial promoters.
High-level expression of a tc eﬄux pump is toxic in the
absence of tc and transcription of the encoding gene, tetA,
is only induced in the presence of the antibiotic (8,9). This
regulation is controlled by a single transcriptional repres-
sor, TetR, which binds to two tet operators (tetOs) in the
tetA promoter. Binding of TetR prevents access of RNA
polymerase to the promoter and inhibits transcription
initiation. Once tc enters the cell it binds to TetR, induces
a conformational change that forces the helix–turn–helix
(HTH) motifs of TetR into positions that interfere with
operator binding and releases the repressor from tetO. The
aﬃnity of tc to TetR is  1000-fold higher than tc’s aﬃnity
to the ribosomes. Expression of tetA is, therefore, induced
at tc concentrations far below those that inhibit transla-
tion (10).
TetRs and tetO-containing promoters have been used to
regulate gene expression in Gram-negative (11,12), Gram-
positive (13–15) and acid-fast bacteria (4,16–18). In most
of these systems, expression of the target gene is induced
by adding tc to the culture. While useful for many experi-
ments, these systems are not ideal if the goal is to study the
consequences of gene silencing, in part, because the
removal of tc is diﬃcult in some experimental settings
(e.g. during hypoxia).
We recently constructed a regulated mycobacterial
expression system that permits to silence a gene by the
addition of atc (5,7). This system makes use of a TetR
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changes (E15A, L17G, and L25V) in the DNA-binding
domain. These mutations reverse the allosteric response
of TetR to binding of tc: whereas binding of tc to wt
TetR causes the repressor to dissociate from DNA, bind-
ing of tc to TetR r1.7 (or other reverse TetRs) causes the
repressor to bind to DNA. Repression by TetR r1.7 was
eﬃcient enough to study the consequences of silencing
secA1 in Mycobacterium smegmatis (7) and prcBA in
M. tuberculosis (5). However, repression by TetR r1.7
requires high-level TetR expression and only occurs if
(i) the tetR gene is transcribed by the strong mycobacterial
promoter Psmyc and (ii) is located on a multicopy plasmid.
Even under these conditions repression by TetR r1.7 with
atc is not as eﬃcient as repression by wt TetR without atc
(7) so that only some mycobacterial genes can be silenced
to the extent necessary to reveal the consequences of their
inactivation (unpublished data).
The wt TetR used by us to control gene expression in
mycobacteria stems from the transposon Tn10, which
encodes the so-called tet(B) tc resistance determinant
(20). In contrast, TetR r1.7 was derived from a chimeric
tetR(BD) gene in which the protein core is encoded by the
tetR gene of the tet(D) resistance determinant (19). Here,
we demonstrate that the low repression eﬃciency of TetR
r1.7 in mycobacteria is in part due to low expression of
some tetR(BD) genes and describe the construction of
new wt TetRs and reverse TetRs that allow more eﬃcient
gene silencing in mycobacteria.
MATERIALS AND METHODS
Plasmids, bacterial strains, media, reagents andmolecular
biology techniques
Bacteria and plasmids used in this study are listed in
Table 1. Plasmids were constructed using standard proce-
dures (details available upon request). Mycobacteria were
grown at 378C on Difco 7H11 agar or in Difco
Middelbrook 7H9 broth with 0.2% v/v glycerol and
0.05% v/v Tween 80. For Mycobacterium bovis BCG the
7H9 medium was supplemented with ADN enrichment
(0.5% BSA, 0.2% dextrose, 0.085% NaCl). Escherichia
coli was grown in Luria-Bertani broth (LB). Antibiotics
were added, where appropriate, at 50mg/ml for myco-
bacteria and 200mg/ml for E. coli (hygromycin B,
Calbiochem) and 15mg/ml for mycobacteria and
30mg/ml for E. coli (kanamycin A, Sigma). Atc was
obtained from Sigma. Preparation of competent cells
and electroporations were performed as described (4).
b-Galactosidase assays
Repression by TetRs and induction with atc was deter-
mined after transformation of M. smegmatis or M. bovis
BCG with the appropriate plasmids. From each transfor-
mation three single colonies were inoculated into 2ml of
7H9 media containing the antibiotics required to select for
plasmid maintenance. After shaking at 378C for 44–48h
(M. smegmatis) or 8–10 days (M. bovis BCG), bacteria
were diluted 100-fold in 1-ml fresh media contained in
96-square-well plates (Beckman). After shaking at 378C
for 20–24h (M. smegmatis) or 3–4 days (M. bovis BCG)
optical densities were measured at 580nm. In a black
96-well plate, 100-ml bacteria were then mixed with
C2FDG (Invitrogen) to a ﬁnal concentration of 30mM
C2FDG (21). The plate was incubated in the dark for
3h at 308C and ﬂuorescence was measured at 515nm
after excitation at 485nm using a spectramax M2 plate
reader (Molecular Devices). Fluorescence intensities were
normalized to cell density and reported as relative ﬂuores-
cence units (RFUs). All measurements were repeated at
least twice.
Preparation ofprotein lysates
Mycobacteria were harvested by centrifugation and
washed with PBS (128mM NaCl, 8.5mM Na2HPO4,
3.5mM KCl, 1.5mM KH2PO4, pH 7.4). Cells were resus-
pended in PBS supplemented with Complete
TM protease
inhibitors (Roche Applied Science), and 0.5ml of the sus-
pension was transferred into a screw-cap vial containing
 250ml of 0.1mm Zirconia/Silica beads (BioSpec). Cells
were broken by shaking in a Precellys 24 homogenizer
(Bertin Technologies) at 6500r.p.m. for 20s three times,
with 5-min incubations on ice in between. Total lysates
were obtained after removing beads and unbroken cells
by centrifugation at 13000r.p.m (13793g) for 1min.
For detection of TetR, total lysates were centrifuged at
13000r.p.m for 45min at 48C in an Eppendorf 5417R
centrifuge to separate the soluble (cytoplasm) and insolu-
ble (cell wall) fractions.
Westernblot analysis
Cell lysates were mixed with an SDS- and b-mercapto-
ethanol-containing loading buﬀer and incubated at
958C for 5min. Proteins were separated by 10% SDS–
polyacrylamide gel electrophoresis (SDS–PAGE) and
transferred to a Protran BA83 nitrocellulose membrane
(Whatman) in an ice cooled container with a constant
current of 120mA in transfer buﬀer (192mM glycine,
25mM Tris, 20% v/v methanol) for 2h. A mixture of
hybridoma supernatant containing monoclonal murine
antibodies mixed 1:1 with Odyssey blocking buﬀer was
used as primary antibodies. For detection of the loading
control dihydrolipoamide acyltransferase (DlaT) a poly-
clonal anti-DlaT serum was used at a 1:10000 dilution.
Odyssey Infrared Imaging System was used for detection.
Molecular modeling
The software DS Viewer Pro and Swiss Pdb viewer was
used to determine amino acid residues contacting mutated
amino acid residues in various reverse TetRs on the basis
of the tetO-bound TetR structure PDB#1qpi (22).
RESULTS
The impact of tetRcodon usageon genesilencing by wt
TetRsin M. smegmatis and M.bovis BCG
Expression of TetRs in mycobacteria might be limited
by the ineﬃcient translation of codons within their
genes that rarely occur in mycobacterial genes. To test
Nucleic Acids Research,2009, Vol.37, No. 6 1779this, we constructed four tetR genes in which codons that
occur infrequently in the M. tuberculosis genome were
mutated to alternative codons, which encode the same
amino acid but occur frequently in the M. tuberculosis
genome. In the ﬁrst of these genes, tetR(Bsyn1–50), the
nucleotides encoding the DNA-binding domain of TetR
(nucleotides 1–150) were derived from a synthetic
DNA fragment in which codon usage was adapted to
that of the M. tuberculosis genome. The correspond-
ing gene encoding the chimeric TetR(BD) protein was
named tetR(BDsyn1–50). The 30 fragments of both,
tetR(Bsyn1–50) and tetR(BDsyn1–50), were from the original
tetR(B) and tetR(D) genes. The remaining two tetR var-
iants, tetR(Bsyn1–207) and tetR(BDsyn1–208), were entirely
derived from synthetic DNAs in which all amino acids
were encoded by codons that occur frequently in the
M. tuberculosis genome.
We ﬁrst analyzed the tetR(B) genes in M. smegmatis
Pmyc1tetO-lacZL5, which contains the Pmyc1tetO-lacZ
expression cassette (7) integrated into the chromo-
somal attachment site of the mycobacteriophage L5.
Mycobacterium smegmatis Pmyc1tetO-lacZL5 displayed a
b-galactosidase activity of  8000 relative ﬂuorescence
units (RFUs). The limit of b-galactosidase detection was
at  70 RFUs. Episomally replicating plasmids containing
tetR downstream of the constitutive promoter Pimyc (23)
were used to express each TetR variant (Figure 1A).
Transformation of M. smegmatis Pmyc1tetO-lacZL5 with
Table 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description Reference
Strain
M. smegmatis mc
2155 Electroporation-proﬁcient M. smegmatis (26)
M. smegmatis MSE10 Hyg
r mc2155 derivative in which secA1 is controlled by Pmyc1tetO. (7)
M. bovis BCG Mycobacterium bovis BCG ATCC #35734
E. coli DH5a F
  f80dlacZ(lacZ)M15 (lacZYA-argF) U169 deoR recA1 endA1hsdR17 (r 
Kmþ
K)
phoA supE44  




r, pAL5000 and ColE1 origins, multiple cloning site (23)
pMV306Km Km
r, ColE1 origin, intL5, attPL5, integrates at attBL5 site (27)
pTT-P1A Km
r, Amp
r, ColE1 origin, inttweety, attPtweety, integrates at attBtweety site (24)
pTE-4M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BD)E15A-L17G-L25V (7)
pTC-0X-1L pMV306 derivative, Pmyc1tetO-lacZ (7)
pTE-1M-0X pMS2 derivative, Hyg
r,P imyc-tetR(B) (7)
pTE-mcs pMS2 derivative, Hyg
r, alternative multiple cloning site containing unique restriction
sites for ClaI, PacI, PmeI and NotI
This study
pTC-mcs pMV306K derivative, Km
r, alternative multiple cloning site containing unique
restriction sites for MluI, NotI, PmeI, PacI, ClaI and SalI
This study
pTE-2M-0X pMS2 derivative, Hyg
r,P imyc-tetR(Bsyn1–50) This study
pTE-10M-0X pMS2 derivative, Hyg
r,P imyc-tetR(Bsyn1–207) This study
pTE-9M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BD) This study
pTE-11M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BDsyn1-50) This study
pTE-12M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BDsyn1-208) This study
pTE-15M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BDsyn1-208)E15A-L17G-L25V This study
pTE-16M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BDsyn1-208)L17G This study
pTE-19M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BDsyn1-208)A56P-V57L-E58V This study
pTE-20M-0X pMS2 derivative, Hyg
r,P imyc-tetR(BDsyn1-208)R94P-V99E This study
pTE-22M-0X pMS2 derivative, Hyg
r,P imyc-tetR(Bsyn1-207)E15A-L17G-L25V This study
pTE-23M-0X pMS2 derivative, Hyg
r,P imyc-tetR#23 This study
pTE-24M-0X pMS2 derivative, Hyg
r,P imyc-tetR#24 This study
pTE-25M-0X pMS2 derivative, Hyg
r,P imyc-tetR#25 This study
pTE-27M-0X pMS2 derivative, Hyg
r,P imyc-tetR#27 This study
pTE-28M-0X pMS2 derivative, Hyg
r,P imyc-tetR #28 This study
pTE-29M-0X pMS2 derivative, Hyg
r,P imyc-tetR#29 This study
pTE-15S15-0X pMS2 derivative, Hyg
r,P smyc-tetR(BDsyn1-208)E15A-L17G-L25V This study
pTE-22 S15-0X pMS2 derivative, Hyg
r,P smyc-tetR(Bsyn1-207)E15A-L17G-L25V This study
pTE-23 S15-0X pMS2 derivative, Hyg
r,P smyc-tetR#23 This study
pTE-24 S15-0X pMS2 derivative, Hyg
r,P smyc-tetR#24 This study
pTE-25 S15-0X pMS2 derivative, Hyg
r,P smyc-tetR#25 This study
pTE-27 S15-0X pMS2 derivative, Hyg
r,P smyc-tetR#27 This study
pTE-28 S15-0X pMS2 derivative, Hyg
r,P smyc-tetR#28 This study
pTE-29 S15-0X pMS2 derivative, Hyg
r,P smyc-tetR#29 This study
pTC-1M-1L pMV306 derivative, Km
r,P myc1tetO-lacZ, Pimyc-tetR(B) This study
pTC-2M-1L pMV306 derivative, Km
r,P myc1tetO-lacZ, Pimyc-tetR(Bsyn1–50) This study
pTC-10M-1L pMV306 derivative, Km
r,P myc1tetO-lacZ, Pimyc-tetR (Bsyn1–207) This study
pTC-4S15-0X pMV306 derivative, Km
r,P smyc-tetR(BD)E15A-L17G-L25V This study
pTC-15S15-0X pMV306 derivative, Km
r,P smyc-tetR(BDsyn1–208)E15A-L17G-L25V This study
pTC-27S15-0X pMV306 derivative, Km
r,P smyc-tetR#28 This study
pTC-28S15-0X pMV306 derivative, Km
r,P smyc-tetR #28 This study
pTT-P1A-S1L pTT-P1A derivative, Strep
r,P myc1tetO-lacZ This study
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ity to  3% of that of M. smegmatis Pmyc1tetO-lacZL5
without tetR (Figure 1B). Strains containing the two syn-
thetic tetR(B) genes, Pimyc-tetR(Bsyn1–50)o rP imyc-
tetR(Bsyn1–207) displayed b-galactosidase activities of
 1%. In M. bovis BCG Pmyc1tetO-lacZL5 the original
tetR(B) gene reduced b-galactosidase activity to 17% of
the activity of M. bovis BCG Pmyc1tetO-lacZL5 without
tetR. In contrast, the two synthetic tetR(B) genes both
caused repression to <1%.
We then measured repression of b-galactosidase activ-
ities by the three tetR(BD) genes in M. smegmatis and
M. bovis BCG. Expression of TetR(B/D) by Pimyc-
tetR(BD) reduced b-galactosidase activities to  20%
and  50%, respectively, of M. smegmatis and M. bovis
BCG without tetR (Figure 1B, gray bars). In contrast,
expression of TetR(B/D) by the synthetic tetR(BD)
genes repressed b-galactosidase activities to levels between
1 and 2%. All strains exhibited between 53 and 102%
b-galactosidase activities in the presence of 300 ng/ml
atc (Figure 1B, black bars).
Next, we determined if the two synthetic tetR(B) genes,
which repressed expression of b-galactosidase more eﬃ-
ciently than the corresponding tetR(B/D) genes, also
allowed eﬃcient gene silencing when integrated into the
chromosome. For this, we cloned each tetR(B) gene
together with the reporter gene cassette, Pmyc1tetO-lacZ,
into one integrative plasmid (Figure 2A). In both,
M. smegmatis and M. bovis BCG, repression was
most eﬃcient with tetR(Bsyn1–207) and least eﬃcient
with tetR(B) (Figure 2B). Repression correlated well
with protein steady-state levels, which were highest with
tetR(Bsyn1–207) and lowest with tetR(B) (Figure 2B). In
summary, these ﬁndings demonstrated that repression by
wt TetRs in M. smegmatis and M. bovis BCG was signiﬁ-
cantly improved by adapting the codon usage of tetR to
that of mycobacteria and that tetR(B) genes mediated
more eﬃcient repression than the corresponding
tetR(BD) genes.
The impact of tetRcodon usageon genesilencing by reverse
TetRsin M. smegmatis
Reverse TetRs allow gene silencing by adding atc instead
of removing atc (Figure 3A), which is advantageous under
conditions were atc cannot be easily depleted (e.g. during
hypoxia). TetR r1.7, a reverse TetR(BD) variant that con-
tained three mutations in its DNA-binding domain
(E15A, L17G and L25V), allowed atc-induced gene silen-
cing in both, M. smegmatis (7) and M. tuberculosis (5).
However, repression by TetR r1.7 was less eﬃcient than
Figure 1. Impact of tetR codon usage adaptation on repression of
chromosomally encoded b-galactosidase activities by episomally
encoded wt TetRs. (A) Genetic organization of the assay strains.
The Pmyc1tetO-lacZ reporter gene cassette was integrated into the
mycobacteriophage L5 attachment site. The Pimyc-tetR genes were
located on episomally replicating plasmids. Binding of TetR to tetOs
in the absence of atc caused repression of Pmyc1tetO. Symbols:
TetRs, gray ovals; tetOs, black boxes; atc, black hexagons. (B)
b-Galactosidase activities (b-gal). Expressed TetR variants are identiﬁed
underneath the graph. Values were normalized to the b-galactosidase
activity measured in the absence of TetR, which was set to 100%. Bars
represent averages of three measurements and are representative of at
least two independent experiments. Error bars indicate standard
deviations.
Nucleic Acids Research,2009, Vol.37, No. 6 1781repression by wt TetR (7). To improve gene silencing by
reverse TetRs we ﬁrst mutated the tetR(BDsyn1–208) gene
to encode TetR r1.7; the resulting gene was named
tetR(BDsyn1–208)E15A-L17G-L25V (in contrast to
tetR(BD)E15A-L17G-L25V, the noncodon usage adapted
gene encoding TetR r1.7) Transformation of M. smegma-
tis Pmyc1tetO-lacZL5 with an episomally replicating plas-
mid containing Pimyc-tetR(BDsyn1–208)E15A-L17G-L25V
reduced b-galactosidase activity to  6% of the strain
without tetR in the presence of atc (Figure 3B). No repres-
sion was observed in the absence of atc. As had been
observed previously (7), Pimyc-tetR(BD)E15A-L17G-
L25V did not change b-galactosidase of M. smegmatis.
We also constructed and analyzed three additional
tetR(BDsyn1–208) derivates which all encoded reverse
TetRs that function eﬃciently in E. coli (19). However,
the most eﬃcient of these repressors reduced b-galactosi-
dase activity only to 22% in M. smegmatis (Figure 3B)
and none of them caused any repression if expressed by
the original, noncodon usage adapted, tetR(BD) genes.
These experiments demonstrated that codon-usage adap-
tation improved gene silencing by TetR r1.7 and that
among the four TetRs evaluated, TetR r1.7 was most eﬃ-
cient in M. smegmatis.
Constructionof improved reverse TetRs
forgene silencing inmycobacteria
All reverse TetRs analyzed so far were originally isolated
in genetic screens using mutants of tetR(BD) (19).
Unfortunately, repression of lacZ by TetR(BD) in
M. smegmatis and M. bovis BCG was less eﬃcient than
repression by TetR(B) (Figure 1B). To determine if the
diﬀerence in repression by TetR(B) and TetR(BD) might
be caused by diﬀerent protein steady state levels, lysates
from M. smegmatis and M. bovis BCG containing Pimyc-
tetR(Bsyn1–207) or Pimyc-tetR(BDsyn1–208) were analyzed
by Western blots. Strong signals were detected for
TetR(B) in lysates from both mycobacteria but the
steady state levels of TetR(BD) were below the level of
detection (Figure 4). This suggested that a reverse TetR
derived from TetR(B) might be more eﬃcient in mycobac-
teria than those derived from TetR(BD). However, so far
no reverse TetR(B) variant had been isolated.
We ﬁrst examined if a reverse TetR(B) could be
constructed by introducing the amino acid exchanges
present in TetR r1.7. Expression of this repressor using
an episomally replicating plasmid containing Pimyc-
tetR(Bsyn1–207)E15A-L17G-L25V did not aﬀect the
b-galactosidase activity of M. smegmatis Pmyc1tetO-lacZL5
with or without atc (Figure 5A). When expressed by the
strong promoter Psmyc, this repressor reduced b-galactosi-
dase activity  5-fold in the presence of atc (data not
shown). No repression was observed in the absence
of atc. TetR(Bsyn1-207)E15A-L17G-L25V thus encoded
a less eﬃcient reverse TetR than the corresponding
tetR(BDsyn1–208) gene (tetR(BDsyn1–208)E15A-L17G-
L25V, Figure 3B) even though the steady-state level of
the TetR(B) protein was higher than that of the
TetR(BD) protein (Figure 5C). This suggested that
Figure 2. Impact of tetR codon usage adaptation on repression of chromosomally encoded b-galactosidase activities by chromosomally encoded
wt TetRs. (A) Genetic organization of the assay strains. Plasmids containing both, the Pmyc1tetO-lacZ reporter gene cassette and the Psmyc-tetR
genes were integrated into the chromosome via the L5 attachement site. Symbols: TetRs, gray ovals; tetOs, black boxes; atc, black hexagons. (B)
b-galactosidase activities (b-gal) and steady-state TetR protein levels detected by a monoclonal anti-TetR antibody. Expressed TetR variants are
identiﬁed underneath the bar graph. Values were normalized to the b-galactosidase activity measured in the absence of TetR, which was set to 100%.
Bars represent averages of three measurements and are representative of at least two independent experiments. Error bars indicate standard
deviations. Western blots are shown below the respective bar graphs. The dihydrolipoamide acyltransferase (DlaT) signal was used as a loading
control and detected by a polyclonal anti-DlaT antibody.
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the corresponding TetR(D) amino acids to not only
achieve an increase in protein expression but also generate
an eﬃcient reverse phenotype.
We hypothesized that the TetR(D) amino acids required
for an eﬃcient reverse phenotype should be located in
close proximity to the amino acids at positions 15, 17
and 25 in the crystal structure of the TetR(D)–tetO com-
plex. Most residues that are (i) diﬀerent in TetR(B) and
TetR(D) and (ii) located in the vicinity of the amino acids
at positions 15, 17 and 25 are in alpha helices four, ﬁve
and the N-terminal and C-terminal regions of helices
seven and eight, respectively (a4, a5, a7, a8)
(Figure 5D). Using the fully codon usage adapted
tetR(Bsyn1–207) and tetR(BDsyn1–208) genes, we con-
structed three derivatives of TetR(B)E15A-L17G-L25V
in which all amino acids located in a4 (TetR#23), a4-a5
(TetR#24) or a4-a7 (TetR#25) were identical to those of
TetR(D) (Figure 5A). Analysis of these TetRs in M. smeg-
matis demonstrated that repression in the presence of atc
increased with the number of TetR(D) residues introduced
into TetR(B)E15A-L17G-L25V (Figure 5A). We next
introduced two additional TetR(D) amino acids—T152
and A153, which are located at the C-terminus of helix 8
and proximal to amino acid L17 and L25 in the TetR(D)–
tetO complex (distance Cb-Cb<15A ˚ ) (Figure 5D)—into
TetR#24 and #25. The resulting repressors were named
TetR#27 and TetR#28, respectively (Figure 5B).
TetR#27 and TetR#28 both repressed the b-galactosidase
activity of M. smegmatis Pmyc1tetO-lacZL5 to <2% of that
of the strain without tetR achieving 3-fold better repres-
sion compared to TetR#24 and TetR#25. None of the
repressors reduced b-galactosidase activities in the absence
of atc.
TetR#27 and TetR#28 both contained TetR(D) amino
acids at position that were not in close proximity of the
TetR DNA-binding domain (e.g. amino acids located in
the loop connecting a4 and a5) (Figure 5D). We therefore
constructed one additional TetR variant, named TetR#29,
in which those amino acids that are located within a radius
of 15A ˚ of residues E15, L17 or L25 were mutated to the
corresponding TetR(D) amino acids, namely M59I, S92R,
H93Y, Q152T and V153A, as well as I57V and D61A
which are located within a radius between 15 and 20A ˚ .
Repression by TetR#29 was slightly less eﬃcient than that
achieved by TetR#27 and #28 (Figure 5B).
Western blots revealed that the lack of repression by
TetR#23 correlated with its low-steady-state level (which
was below the level of detection) (Figure 5C). The diﬀer-
ences in repression by the other TetR variants, however,
cannot be explained by diﬀerences in their expression. For
example, the steady-state level of TetR#27 is lower than
that of TetR#29 but TetR#27 is the more eﬃcient repres-
sor. This suggests that some or all of the TetR(D) amino
acids present in TetR#27 and missing in TetR#29 are
involved in the atc-induced allosteric transition required
for repression. In summary, this work led to the construc-
tion of more eﬃcient reverse TetRs for mycobacteria and
identiﬁed regions in the TetR protein core required for
eﬃcient tetO binding.
Gene silencing by chromosomally integratedreverse tetRs
A limitation of the previously described TetR r1.7 is the
requirement for expression by a multicopy plasmid
to achieve eﬃcient repression in mycobacteria. We
tested if the new reverse TetRs would allow the repres-
sion of a target gene if expressed by a chromosomally
Figure 3. Impact of tetR codon usage adaptation on repression of
chromosomally encoded b-galactosidase activities by episomally
encoded reverse TetRs. (A) Genetic organization of the assay strains.
The Pmyc1tetO-lacZ reporter gene cassette was integrated into the
mycobacteriophage L5 attachment site. The Pimyc-tetR genes were
located on episomally replicating plasmids. Binding of revTetR to
tetOs in the presence of atc caused repression of Pmyc1tetO. Symbols:
TetRs, gray ovals; tetOs, black boxes; atc, black hexagons. (B)
b-galactosidase activities (b-gal). Expressed TetR variants are identiﬁed
underneath the bar graph. Values were normalized to the b-galactosi-
dase activity measured in the absence of TetR, which was set to 100%.
Bars represent averages of three measurements and are representative
of at least two independent experiments. Error bars indicate standard
deviations.
Nucleic Acids Research,2009, Vol.37, No. 6 1783Figure 5. Analysis of reverse TetR chimeras in M. smegmatis.( A) b-galactosidase activities (b-gal). Expressed TetR variants are speciﬁed left of the
bar graph. In the schemas on the left, gray and black rectangles indicate sequences derived from tetR(B) and tetR(D) respectively. Red stars indicate
the location of mutation causing the reverse phenotype of TetR r1.7. Blue stars indicate TetR(B) to TetR(D) mutations. b-Gal values were
normalized to the b-galactosidase activity measured in the absence of TetR, which was set to 100%. Bars represent averages of three measurements
and are representative of at least two independent experiments. Error bars indicate standard deviations. (B) b-galactosidase activities (b-gal). As
described for (A). (C) Western blots. Protein lysates were prepared from M. smegmatis expressing TetR variants encoded by episomally replicating
plasmids. TetR was detected by a monoclonal anti-TetR antibody (lower panel) and the dihydrolipoamide acyltransferase (DlaT) signal was used as
a loading control and detected by a polyclonal anti-DlaT antibody (upper panel). (D) Structure of tetO-bound TetR(D) (22). The two monomers
are shown in light and dark gray. The side chains of the amino acids that are mutated in and cause the reverse phenotype of TetR r1.7 are shown in
red. In the dark gray monomer helices 4 to 7 are drawn in yellow. Side chains that are diﬀerent in TetR(B) and TetR(D) and within a radius of 15A ˚
to positions 15, 17 and 25 are shown in light blue (for clarity sake only within one monomer).
Figure 4. Comparison of TetR steady state levels in M. smegmatis and M. bovis BCG containing tetR(B)syn1–207 or tetR(BD)syn1–208. Protein
lysates were from M. smegmatis (labeled ‘Msm’) and M. bovis BCG (labeled ‘BCG’) containing episomally replicating Pimyc-tetR plasmids.
A monoclonal anti-TetR antibody recognizing an epitope within the DNA-binding region of TetR was used to detect puriﬁed TetR as well as
TetR in protein lysates from M. smegmatis and M. bovis BCG. The DlaT signal was used as a loading control and detected by a polyclonal anti-
DlaT antibody.
1784 Nucleic Acids Research, 2009, Vol. 37,No. 6integrated tetR. For this we cloned four tetRs, the original
tetR(BD)E15A-L17G-L25V, tetR(BDsyn1–208)E15A-
L17G-L25V, tetR#27 and tetR#28, into expression plas-
mids that can integrate in the chromosomal attachment
site of the mycobacteriophage L5. These constructs were
evaluated in M. smegmatis Pmyc1tetO-lacZtweety, which
contained the lacZ reporter integrated into the chromo-
somal attachment site of the mycobacteriophage tweety
(Figure 6A) (24). Chromosomal expression of TetR#27
and #28 reduced the b-galactosidase of M. smegmatis
Pmyc1tetO-lacZtweety to <2% (Figure 6B). In contrast
b-galactosidase activities of the strains containing
tetR(BD)E15A-L17G-L25V or tetR(BDsyn1–208)E15A-
L17G-L25V, both of which encode TetR r1.7, were 10%
and 6%, respectively. A comparison of repression by TetR
r1.7 and TetR#28 with diﬀerent atc concentrations
demonstrated that TetR#28 not only caused more eﬃcient
repression at high atc concentrations but also was more
responsive to low levels of atc.
To conﬁrm these results by an independent test, we
transformed M. smegmatis MSE10 with chromosomally
integrating plasmids containing Psmyc-tetR(BD)E15A-
L17G-L25V, Psmyc-tetR(BDsyn1–208)E15A-L17G-L25V,
Psmyc-tetR#27,o rP smyc-tetR#28. M. smegmatis MSE10
is a mutant in which the native promoter of the essential
secA1 gene has been replaced by Pmyc1tetO so that tran-
scription of secA1 and growth of M. smegmatis can be
controlled with TetRs (7). The outgrowth of these trans-
formations was spread on selective 7H11 media containing
either no or 300ng/ml atc and pictures were taken after 3
days of incubation at 378C. Expression of TetR r1.7 by a
chromosomally integrated tetR(BD)E15A-L17G-L25V
did not aﬀect growth of this M. smegmatis MSE10
(Supplementary Figure 2). Expression of TetR r1.7 using
a chromosomally integrated copy of the codon usage
adapted tetR(BDsyn1-208)E15A-L17G-L25V gene did
decrease but not entirely suppress growth in the presence
of atc. In contrast, no growth on atc plates was observed
for the strains containing chromosomally integrated genes
encoding TetR#27 or #28. All strains grew similarly on
plates without atc. In summary these experiments demon-
strated that the new reverse TetRs show signiﬁcantly
improved repression and atc responsiveness.
Analysisof selected reverse TetRs in M.bovis BCG
To determine if tetR#27 and tetR#28 also mediated more
eﬃcient repression in slow growing mycobacteria we com-
pared them with tetR(BDsyn1–208)E15A-L17G-L25V in
M. bovis BCG containing the Pmyc1tetO-lacZ reporter
integrated into the mycobacteriophage L5 attachment
site. The weak promoter Pimyc and the strong promoter
Psmyc were used to express each tetR gene. When expressed
from Pimyc, none of the TetRs caused repression of
b-galactosidase activity (Figure 7). However, M. bovis
Figure 6. Repression of lacZ by chromosomally encoded reverse
TetRs. (A) Genetic organization of the assay strains. The Pmyc1tetO-
lacZ reporter gene cassette was integrated into the mycobacteriophage
tweety attachment site. The Psmyc-tetR genes were integrated into the
mycobacteriophage L5 attachment site. Symbols: TetRs, gray ovals;
tetOs, black boxes; atc, black hexagons. (B) b-galactosidase activities
(b-gal) with 300ng/ml atc. Expressed TetR variants are speciﬁed below
the bar graph. b-gal values were normalized to the b-galactosidase activ-
ity measured in the absence of TetR, which was set to 100%. Bars
represent averages of three measurements and are representative of
at least two independent experiments. Error bars indicate standard
deviations. (C) b-galactosidase activities (b-gal) with diﬀerent atc
concentrations. Black circles and gray triangles represent data from
M. smegmatis containing Psmyc-tetR(BD)E15A-L17G-L25V and
Psmyc-tetR#28, respectively.
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containing tetR(BDsyn1–208)E15A-L17G-L25V, tetR#27
or tetR#28 downstream of Psmyc, displayed b-galactosi-
dase activities that were repressed by a factor of 3, 7 or
10, respectively. This repression was only observed in the
presence of atc. TetR#27 and TetR#28, thus, also function
more eﬃciently than TetR r1.7 in M. bovis BCG.
DISCUSSION
The phenotypes of loss-of-function mutants greatly con-
tributed to our understanding of the biology of mycobac-
teria (25). Constitutive loss-of-function mutants are,
however, of limited value for the analysis of genes that
are essential for growth in vitro. The inability to recover
loss-of-function mutants can identify a gene as essential
for in vitro growth. However, the underlying mechanism
may remain unknown. For example, this is true for
approximately one-third of the M. tuberculosis genes
required for optimal growth on agar plates (2). It also
remains unknown if a gene required for growth on agar
plates is required for growth in other environments or is
required for survival under conditions that suppress rep-
lication but permit survival (e.g. during starvation). One
approach that can overcome the limitations of constitutive
loss-of-function mutants is to generate conditional loss-of-
function mutants in which transcription of the only func-
tional copy of the target gene can be repressed. To allow
this in mycobacteria, several regulated mycobacterial
expression systems that make use of TetRs from E. coli
or Corynebacterium glutamicum have recently been con-
structed (4,16–18). Here we described the design of new
TetRs that were derived from the tetR(B) and tetR(D)
repressors and improved to regulate gene expression in
mycobacteria. We ﬁrst analyzed repression mediated by
wt tetR(B) and tetR(BD) genes whose codon usage
was either that of the original genes or adapted to that
of the M. tuberculosis genome. Codon usage adaptation
improved repression between  3-fold (episomal expres-
sion of tetR(B) in M. smegmatis) and  50-fold (episomal
expression of tetR(BD) in M. bovis BCG) (Figure 1). This
improvement is a consequence of increased TetR steady-
state levels (Figure 2) most likely caused by more eﬃcient
translation of the codon usage adapted mRNAs.
Importantly, the increased TetR steady-state levels did
not interfere with induction by atc (Figures 1 and 2).
Codon-usage adaptation of the gene encoding the
reverse repressor TetR r1.7 also improved repression
(Figure 3). However, even after codon-usage adaptation
repression was not as eﬃcient as for wt TetR. Three
repressors containing other mutations, all of which
caused reverse TetR phenotypes in E. coli, were analyzed
but none were more eﬃcient than TetR r1.7 (Figure 3). To
improve repression, we next used a strategy that was based
on (i) the observation that TetR(B) accumulated to higher
steady-state levels in mycobacteria than TetR(BD)
(Figure 4) and (ii) the fact that all reverse TetRs that
had been tested so far were TetR(BD) mutants. The
reverse phenotype of TetR r1.7 is caused by three muta-
tions (E15A, L17G and L25V) within the DNA-binding
domain (Figure 5D). Introduction of these mutations into
the codon usage adapted tetR(B) resulted in a reverse
TetR(B) (data not shown). However, repression by
TetR(B)E15A-L7G-L25V was less eﬃcient than by TetR
r1.7 even though the steady-state levels were higher
for TetR(B)E15A-L17G-L25V than for TetR r1.7
(Figure 5C). This suggested an interference of the
TetR(B) protein core with the allosteric change required
for eﬃcient repression by the reverse (TetR-atc) complex.
We reasoned that the amino acids responsible for this
interference should be located close to amino acids 15,
17 and/or 25 in the TetR-tetO crystal structure
(Figure 5D). To test this hypothesis we constructed several
derivatives of TetR(B)E15A-L17G-L25V in which these
TetR(B) amino acids were exchanged to the respective
TetR(D) amino acids.
Amino acids that are diﬀerent in TetR(B) and TetR(D)
and within a radius of 15A ˚ (distance Cb-Cb) to amino
acids 15, 17 and/or 25 are located within the C-terminal
region of a4, the turn between a5 and a6, and the C-ter-
minus of a8 (Figure 5D). Exchanging all amino acids
located in a4–a7 to the respective TetR(D) residues led
to a repressor, TetR#25, which caused an  25-fold repres-
sion in M. smegmatis. The steady-state protein level of
TetR#25 was higher than that of TetR r1.7 but lower
than that of TetR(B)E15A-L17G-L25V. Its increased
activity was, thus, the result of achieving high expression
without interfering with atc induced tetO binding.
Repressors that only contained the TetR(D) residues
located in a4 (TetR#23) or a4 and a5 (TetR#24) were
Figure 7. Analysis of reverse TetRs in M. bovis BCG. TetR-mediated
repression was measured using the chromosomally integrated
Pmyc1tetO-lacZ reporter. TetR variants were expressed from episomally
replicating plasmids. b-galactosidase activities were analyzed in the
absence (light gray bars) and presence of 300ng/ml atc (dark gray
bars) using a ﬂuorescent-based assay as explained in ‘Materials and
methods’ sections. Obtained values were normalized to the b-galactosi-
dase activity measured in the absence of TetR, which was set to 100%.
Bars represent averages of three measurements and are representative
of at least two independent experiments. Error bars indicate standard
deviations.
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amino acids 152 and 153 to the respective TetR(D) resi-
dues within TetR#25 (leading to TetR#28) further
improved repression to  70-fold. A similar improvement
was observed by introducing these mutations into
TetR#24 (leading to TetR#27). In both cases, the muta-
tions at positions 152 and 153 hardly aﬀected TetR pro-
tein levels, suggesting that the improved repression
properties are due to an improved atc induced tetO-bind-
ing caused by these mutations. TetR#28 contained a total
of 25 TetR(B) to TetR(D) mutations only ﬁve of which
aﬀected amino acids located close to amino acids 15, 17
and/or 25. However, a TetR(B)E15A-L17G-L25V mutant
in which only these ﬁve amino acids plus two additional
positions in helix 4 were mutated (TetR#29) was a less
eﬃcient repressor than TetR#27 and TetR#28 even
though its steady-state level was higher (Figure 5C).
Some or all of the mutations included in TetR#27/28
thus likely contribute to atc induced tetO binding.
The previously described TetR r1.7 did not permit gene
silencing when expressed by a chromosomally integrated
gene. In contrast, TetR#27 and TetR#28 caused  50-fold
repression of b-galactosidase activities in M. smegmatis
when expressed by a chromosomally integrated gene
(Figure 6B) and caused eﬃcient repression even at low
atc concentrations (Figure 6C). The new reverse TetRs
furthermore allowed eﬃcient silencing of the essential
secA1 gene in a conditional M. smegmatis knockdown
mutant when expressed by a chromosomally integrated
gene (Supplementary Figure 2). Repression by any of
the reverse TetRs in M. bovis BCG was not as eﬃcient
as in M. smegmatis. However, TetR#27 and TetR#28 were
also more eﬃcient in this slow growing mycobacterium
than the previously described TetR r1.7 (Figure 7).
These new reverse TetRs will therefore likely extend the
spectrum of genes that can be eﬃciently silenced in fast
and slow growing mycobacteria.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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